Vous n'êtes pas identifié (connexion)

Centre de recherche

VENDREDI 15 DÉC

Calendrier >

CARRIÈRES

Liste des opportunités >

BOTTIN

Alain Bélanger

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Endocrinologie et néphrologie
Adresse(s)
Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier
T-3-67
Québec (Québec)
CANADA G1V 4G2

Téléphone(s)
+1 418-656-4141, poste 46442
Télécopieur(s)
+1 418-654-2298
Courriel(s)
alain.belanger@ap.ulaval.ca

Publications récentes (voir toutes les publications de ce chercheur)

Labrie F, Martel C, Belanger A, Pelletier G. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology. The Journal of steroid biochemistry and molecular biology,  2017. 168: 9-18
Belanger A, Utian W. To the Editor. Menopause (New York, N.Y.) ,  2017. 24: 988
Labrie F, Belanger A, Pelletier G, Martel C, Archer DF, Utian WH. Science of intracrinology in postmenopausal women. Menopause (New York, N.Y.) ,  2017. 24: 702-712
Ke Y, Belanger A, Simard JN, Gonthier R, Martel C, Vaillancourt M, Labrie F. Concentration range of serum sex steroids in normal postmenopausal women and those with diagnosis of vulvovaginal atrophy. Menopause (New York, N.Y.) ,  2017. Epub
Labrie F, Ke Y, Gonthier R, Belanger A. Why both LC-MS/MS and FDA-compliant validation are essential for accurate estrogen assays? The Journal of steroid biochemistry and molecular biology,  2015. 149: 89-91
Labrie F, Ke Y, Gonthier R, Belanger A. Reprint of "Why both LC-MS/MS and FDA-compliant validation are essential for accurate estrogen assays?". The Journal of steroid biochemistry and molecular biology,  2015. 153: 54-6
Gauthier-Landry L, Belanger A, Barbier O. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution. The Journal of steroid biochemistry and molecular biology,  2015. 145: 187-92
Ekstrom L, Cevenini L, Michelini E, Schulze J, Thorngren JO, Belanger A, Guillemette C, Garle M, Roda A, Rane A. Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes. European journal of clinical investigation,  2013. 43: 248-55
Grosse L, Paquet S, Caron P, Fazli L, Rennie PS, Belanger A, Barbier O. Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications. Cancer research,  2013. 73: 6963-71
Paquet S, Fazli L, Grosse L, Verreault M, Tetu B, Rennie PS, Belanger A, Barbier O. Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression. The Journal of clinical endocrinology and metabolism,  2012. 97: E428-32
© 2017 Tous droits réservés Centre de recherche du CHU de Québec